Caterpillar Inc. (CAT) vs Eli Lilly and Company (LLY)
See how Caterpillar Inc. and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.
$880.28
NYSE
Caterpillar Inc. is the world’s leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. The company reports results across Construction Industries, Resource Industries, and Energy & Transportation, with market share nearing 20% in many product categories. Caterpillar also operates a captive finance subsidiary that helps support equipment sales. Its business has a broad global footprint, with revenue roughly balanced between the United States and international markets. The construction segment is more heavily weighted toward the domestic market, while the other divisions are more geographically diversified. An independent dealer network of more than 150 dealers runs approximately 2,800 locations, extending Caterpillar’s sales and service presence to about 190 countries.
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.